Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Karmanos Cancer Institute at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Karmanos Cancer Institute brings 8 presentations to ASH 2026 in New Orleans. Its research centres on acute myeloid leukemia and other myeloid cancers. Posters cover FLT3-ITD length, menin inhibitor resistance and epigenetic age changes in GATA2- and DDX41-linked disease.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
Comprehensive cancer center in Detroit, Michigan, providing cancer treatment and research, part of McLaren Health Care.
Session
Mon Dec 14
4:30pm–5:45pm
Multiple Myeloma: The Future is Now
Multiple myeloma care today, covering T-cell redirecting therapy at early relapse, options after CAR-T failure, and maintenance for high-risk patients.
Myeloma

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Karmanos Cancer Institute

Tell us what you sell and we’ll find the people at Karmanos Cancer Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction